Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma
Authors:
- Elena BonazzoliEBElena Bonazzoli
- Stefania BelloneSBStefania Bellone
- Luca ZammataroLZLuca Zammataro
- Barbara GnuttiBGBarbara Gnutti
- Silvia PelligraSPSilvia Pelligra
- Nupur NagarkattiNNNupur Nagarkatti
- Joan Tymon-RosarioJTJoan Tymon-Rosario
- Burak ZeybekBZBurak Zeybek
- Gary AltwergerGAGary Altwerger
- Gulden MenderesGMGulden Menderes
Open Access
- 26 June 2020
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 158 (3) , 769-775
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 26 references indexed in Scilit:
- Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15Genes & Development, 2013
- Targeting MYC dependence in cancer by inhibiting BET bromodomainsProceedings of the National Academy of Sciences of the United States of America, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaNature, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoproteinNature Cell Biology, 2008
- FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiationNature Reviews Cancer, 2008
- Structure of a Fbw7-Skp1-Cyclin E Complex: Multisite-Phosphorylated Substrate Recognition by SCF Ubiquitin LigasesMolecular Cell, 2007
- HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalitiesGynecologic Oncology, 2006
- A possible tumor suppressor role of the KLF5 transcription factor in human breast cancerOncogene, 2002